Global Dermatology Medications and Solutions Market (By Type of Diseases- Acne, Allergic Dermatology, Rashes, Dermatitis, Actinic Keratosis and Others. By Distribution Channel- Hypermarkets/ Supermarkets, Pharmaceutical Stores and Online Market. By Product Type- Ointments, Antihistamines, Antibiotics and Laser Therapy. By End-Use- Skincare Clinics, Dermatology Clinics and Hospitals) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025
The report covers the analysis and forecast of the Dermatology and solutions market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).
The study provides a detailed view of the Dermatology and solutions market, by segmenting it based on by type of diseases, by distribution channel, by end-use, by product type and regional demand. Increasing skin related diseases around the world drives the growth of this market. Moreover, product innovation made by the leading manufacturing companies also makes the market demanding.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the Dermatology and solutions market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Dermatology and solutions market.
The report provides the size of the Dermatology and solutions market in 2016 and the forecast for the next nine years up to 2025. The size of the global Dermatology and solutions market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The Dermatology and solutions market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the Dermatology and solutions market, split into regions. Based on, type of diseases, distribution channel, end-use and product type, the individual revenues from all the regions is summed up to achieve the global revenue for Dermatology and solutions market. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of Dermatology and solutions several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Celgene Corporation, Galderma S.A., Pfizer Inc., GlaxoSmithKline Limited and few more.
The global Dermatology and solutions market has been segmented into:
Global Dermatology and Solutions Market: By Type of Diseases
The study provides a detailed view of the Dermatology and solutions market, by segmenting it based on by type of diseases, by distribution channel, by end-use, by product type and regional demand. Increasing skin related diseases around the world drives the growth of this market. Moreover, product innovation made by the leading manufacturing companies also makes the market demanding.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the Dermatology and solutions market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Dermatology and solutions market.
The report provides the size of the Dermatology and solutions market in 2016 and the forecast for the next nine years up to 2025. The size of the global Dermatology and solutions market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The Dermatology and solutions market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the Dermatology and solutions market, split into regions. Based on, type of diseases, distribution channel, end-use and product type, the individual revenues from all the regions is summed up to achieve the global revenue for Dermatology and solutions market. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of Dermatology and solutions several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Celgene Corporation, Galderma S.A., Pfizer Inc., GlaxoSmithKline Limited and few more.
The global Dermatology and solutions market has been segmented into:
Global Dermatology and Solutions Market: By Type of Diseases
- Acne
- Allergic Skin Diseases
- Rashes
- Dermatitis
- Actinic Keratosis
- Others
- Hypermarket/ Supermarket
- Pharmaceutical Stores
- Online Market
- Skincare Clinics
- Dermatology Clinics
- Hospitals
- Ointments
- Antihistamines
- Antibiotics
- Laser Therapy
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Rest of Latin America
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET SNAPSHOT
3.2 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY TYPE OF DISEASE
5.1 OVERVIEW
5.2 ACNE
5.3 ALLERGIC SKIN DISEASES
5.4 RASHES
5.5 DERMATITIS
5.6 ACTINIC KERATOSIS
5.7 OTHERS
6 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY DISTRIBUTION CHANNEL
6.1 OVERVIEW
6.2 HYPERMARKET/ SUPERMARKET
6.3 PHARMACEUTICAL STORES
6.4 ONLINE MARKET
7 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY END-USE
7.1 OVERVIEW
7.2 SKINCARE CLINICS
7.3 DERMATOLOGY MEDICATIONS CLINICS
7.4 HOSPITALS
8 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 OINTMENTS
8.3 ANTIHISTAMINES
8.4 ANTIBIOTICS
8.5 LASER THERAPY
9 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.1.1 DRIVERS
9.1.1.2 RESTRAINS
9.1.1.3 OPPORTUNITY
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.1.1 DRIVERS
9.2.1.2 RESTRAINS
9.2.1.3 OPPORTUNITY
9.2.2 U.K.
9.2.3 FRANCE
9.2.4 GERMANY
9.2.5 SPAIN
9.2.6 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.1.1 DRIVERS
9.3.1.2 RESTRAINS
9.3.1.3 OPPORTUNITY
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.1.1 DRIVERS
9.4.1.2 RESTRAINS
9.4.1.3 OPPORTUNITY
9.4.2 SOUTH AFRICA
9.4.3 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.1.1 DRIVERS
9.5.1.2 RESTRAINS
9.5.1.3 OPPORTUNITY
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA
10 COMPETATIVE LANDSCAPE
10.1 OVERVIEW
10.2 NEW PRODUCT LAUNCHES
11 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY COMPANY
11.1 INTRODUCTION
11.2 CELGENE CORPORATION
11.2.1 BUSINESS OVERVIEW
11.2.2 PRODUCTS & SERVICES
11.2.3 KEY STRATEGY
11.2.4 RECENT DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.3 ELI LILLY AND COMPANY
11.3.1 BUSINESS OVERVIEW
11.3.2 PRODUCTS & SERVICES
11.3.3 KEY STRATEGY
11.3.4 RECENT DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.4 GALDERMA S.A.
11.4.1 BUSINESS OVERVIEW
11.4.2 PRODUCTS & SERVICES
11.4.3 KEY STRATEGY
11.4.4 RECENT DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.5 ALMIRALL S.A.
11.5.1 BUSINESS OVERVIEW
11.5.2 PRODUCTS & SERVICES
11.5.3 KEY STRATEGY
11.5.4 RECENT DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.6 PFIZER INC.
11.6.1 BUSINESS OVERVIEW
11.6.2 PRODUCTS & SERVICES
11.6.3 KEY STRATEGY
11.6.4 RECENT DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.7 INCYTE CORPORATION
11.7.1 BUSINESS OVERVIEW
11.7.2 PRODUCTS & SERVICES
11.7.3 KEY STRATEGY
11.7.4 RECENT DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.8 GLAXOSMITHKLINE LIMITED
11.8.1 BUSINESS OVERVIEW
11.8.2 PRODUCTS & SERVICES
11.8.3 KEY STRATEGY
11.8.4 RECENT DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.9 NOVARTIS INTERNATIONAL
11.9.1 BUSINESS OVERVIEW
11.9.2 PRODUCTS & SERVICES
11.9.3 KEY STRATEGY
11.9.4 RECENT DEVELOPMENTS
11.9.5 SWOT ANALYSIS
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET SNAPSHOT
3.2 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY TYPE OF DISEASE
5.1 OVERVIEW
5.2 ACNE
5.3 ALLERGIC SKIN DISEASES
5.4 RASHES
5.5 DERMATITIS
5.6 ACTINIC KERATOSIS
5.7 OTHERS
6 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY DISTRIBUTION CHANNEL
6.1 OVERVIEW
6.2 HYPERMARKET/ SUPERMARKET
6.3 PHARMACEUTICAL STORES
6.4 ONLINE MARKET
7 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY END-USE
7.1 OVERVIEW
7.2 SKINCARE CLINICS
7.3 DERMATOLOGY MEDICATIONS CLINICS
7.4 HOSPITALS
8 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 OINTMENTS
8.3 ANTIHISTAMINES
8.4 ANTIBIOTICS
8.5 LASER THERAPY
9 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.1.1 DRIVERS
9.1.1.2 RESTRAINS
9.1.1.3 OPPORTUNITY
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.1.1 DRIVERS
9.2.1.2 RESTRAINS
9.2.1.3 OPPORTUNITY
9.2.2 U.K.
9.2.3 FRANCE
9.2.4 GERMANY
9.2.5 SPAIN
9.2.6 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.1.1 DRIVERS
9.3.1.2 RESTRAINS
9.3.1.3 OPPORTUNITY
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.1.1 DRIVERS
9.4.1.2 RESTRAINS
9.4.1.3 OPPORTUNITY
9.4.2 SOUTH AFRICA
9.4.3 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.1.1 DRIVERS
9.5.1.2 RESTRAINS
9.5.1.3 OPPORTUNITY
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA
10 COMPETATIVE LANDSCAPE
10.1 OVERVIEW
10.2 NEW PRODUCT LAUNCHES
11 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY COMPANY
11.1 INTRODUCTION
11.2 CELGENE CORPORATION
11.2.1 BUSINESS OVERVIEW
11.2.2 PRODUCTS & SERVICES
11.2.3 KEY STRATEGY
11.2.4 RECENT DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.3 ELI LILLY AND COMPANY
11.3.1 BUSINESS OVERVIEW
11.3.2 PRODUCTS & SERVICES
11.3.3 KEY STRATEGY
11.3.4 RECENT DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.4 GALDERMA S.A.
11.4.1 BUSINESS OVERVIEW
11.4.2 PRODUCTS & SERVICES
11.4.3 KEY STRATEGY
11.4.4 RECENT DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.5 ALMIRALL S.A.
11.5.1 BUSINESS OVERVIEW
11.5.2 PRODUCTS & SERVICES
11.5.3 KEY STRATEGY
11.5.4 RECENT DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.6 PFIZER INC.
11.6.1 BUSINESS OVERVIEW
11.6.2 PRODUCTS & SERVICES
11.6.3 KEY STRATEGY
11.6.4 RECENT DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.7 INCYTE CORPORATION
11.7.1 BUSINESS OVERVIEW
11.7.2 PRODUCTS & SERVICES
11.7.3 KEY STRATEGY
11.7.4 RECENT DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.8 GLAXOSMITHKLINE LIMITED
11.8.1 BUSINESS OVERVIEW
11.8.2 PRODUCTS & SERVICES
11.8.3 KEY STRATEGY
11.8.4 RECENT DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.9 NOVARTIS INTERNATIONAL
11.9.1 BUSINESS OVERVIEW
11.9.2 PRODUCTS & SERVICES
11.9.3 KEY STRATEGY
11.9.4 RECENT DEVELOPMENTS
11.9.5 SWOT ANALYSIS
